Bitcoin could reach $135,000 by the year-end in a base case scenario or surge as much as $199,000 in a bullish case backed by increasing demand for spot exchange-traded funds (ETFs), according to Citi analysts.
In a bearish scenario, influenced by weaker macroeconomic conditions, the analysts project that Bitcoin could fall to around $64,000.
As the US tariff machine rolls on, the consequences are beginning to hit closer to home. In this commentary, Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW), examines the growing impact of tariffs on American consumers, businesses, and markets. With a new wave of duties—possibly targeting pharmaceuticals—set to take effect August 1, Holmes outlines why investors should brace for higher prices, increased uncertainty, and mounting pressure on key sectors.
U.S. customs duties topped $100 billion for the first time ever in a single year this month. That number is even more remarkable when you consider that most of President Donald Trump’s new tariffs haven’t even taken full effect yet.
TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) is about to make a strategic shift in its business model and position itself as a revenue-generating royalty firm, according to analysts at Fundamental Research Corp.
Production began earlier this year at the Mariana lithium project, owned by China’s Ganfeng Lithium, with TNR set to begin receiving royalty payments as early as the fourth quarter of 2025.
Mirriad Advertising PLC (AIM:MIRI, OTCQX:MMDDF) shares surged 15% on Friday after the company secured a two-year deal with MBC Media Solutions, the advertising division of Middle East broadcaster MBC Group.
Under the agreement, Mirriad will provide exclusive virtual in-video advertising services across MBC’s subscription and linear TV channels.
Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) has announced a further amendment to the terms of its previously disclosed financing under the listed issuer financing exemption (LIFE).
Under the updated terms, the company plans to raise a minimum of $1 million and up to $5 million through the sale of up to 16.67 million units priced at $0.30 per unit.
Ocean Power Technologies Inc (NYSE-A:OPTT) has announced its financial results for the fiscal year ended April 30, 2025, reporting a 6% jump in annual revenue to $5.9 million.
OPT’s backlog surged 155% to $12.5 million, while the pipeline of potential projects grew to $137.5 million, an 88% year-over-year increase.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF), a Canadian clinical-stage drug development company, said it has closed the second tranche of a non-brokered private placement, raising total gross proceeds of C$761,000 from the sale of subscription receipts.
The financing, first announced on May 27 and updated on June 30, includes C$90,000 from company insiders.
Mirriad Advertising PLC (AIM:MIRI, OTCQX:MMDDF) has entered into a two-year services agreement with MBC Media Solutions FZ-LLC. MBC is the advertising arm of MBC Group, a satellite broadcasting company operating in the Middle East and North Africa.
Under the deal, Mirriad will deliver virtual in-video advertising services across MBC’s subscription and linear platforms.
Coinsilium Group Limited (AQSE:COIN, OTCQB:CINGF) told investors it has raised £500,000 of gross proceeds in its WRAP Retail Offer, which was substantially oversubscribed.
The equity raise was priced at 6p per share, and, some 8.33 million shares will now be issued. The firm noted that the process saw demand equivalent to four times the offer size.
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) earlier this week sat down with Proactive to discuss the results of the first 16 holes from an 80-hole drilling campaign at its Mount York Gold Project in Western Australia.
Race Oncology Ltd (ASX:RAC, OTC:RAONF) earlier this week highlighted its quarter milestones, noting it had treated the first patient in a clinical study of RC220, its reformulated version of bisantrene. The company said RC220 resolves solubility issues that limited the original compound’s use in clinical settings and now enables broader application beyond leukemias to include solid tumours. CEO Daniel Tillett sat down with Proactive to discuss the company's quarterly milestones.
West Wits Mining earlier this week released an updated Definitive Feasibility Study (DFS) for the Qala Shallows project, part of the Witwatersrand Basin Project in South Africa. The company said the revised study shows a 58.00% increase in forecast revenue, now estimated at US$2.70 billion. Chairman Michael Quinert sat down with Proactive to discuss.
Key drivers of the uplift are:
Lanthanein Resources Ltd (ASX:LNR, OTC:FRNRF) has delivered a robust quarterly update for the three months ending June 30, 2025, reporting progress at the Lady Grey Project in Western Australia, completion of diamond drilling and new capital raising initiatives aimed at bolstering its exploration efforts.
The company is also taking strategic steps with leadership changes, including the appointment of a new chairman, as it moves forward with exploration and value-enhancing activities.
Regenerative medicine company Orthocell Ltd (ASX:OCC, OTC:ORHHF) will implement a series of board changes to support its global expansion and sharpen its commercial focus, particularly in the United States. The Hon Kim Beazley AC will step down from his role as independent non-executive director for health reasons, but will remain an advisor on US and defence matters. Former Deloitte Perth managing partner Michael McNulty will join as non-executive director and chair of the Audit Committee from September 1, 2025.
Meanwhile, US-based Director Dr Ravi Thadhani has been promoted to lead independent director and will chair a new committee focused on commercialising the company’s flagship nerve repair product, Remplir™, in the US. The board changes follow recent appointments of Jim Piper as chief financial officer and Adam Wood as chief commercial officer.